PATENT CLAIM ANALYSIS

Application Number: 16257586
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["340", "309700"]

Abstract:
Methods of patient compliance using a dosage distribution system to prevent contrast-induced acute injury by administering an inhibitor of fatty acid oxidation to a patient in need thereof. Also provided are methods involving use of dosage distribution system with trimetazidine or pharmaceutically acceptable salts thereof for the prevention and/or treatment of contrast-induced acute kidney injury in a subject in need thereof.

Claim (Index 15):
The method of  claim 1 , wherein dosage distribution system sends a reminder to take trimetazidine or a pharmaceutically acceptable salt thereof for more than 60 days after undergoing a cardiac procedure.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 99.0
- Lexical Diversity: 1.43182
- Patent Class: 340.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12972949', '15719636', '14889594', '12959321', '14240380']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6529139250613252
- 35 USC 102 Novelty (BERT): 0.5250771053828363
- Combined Prediction Score: 0.6401302430934763
- Mean Citation Score: 177.76622
- Max Citation Score: 185.48457
- Similarity Product: 95.20170112147808

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test